Literature DB >> 20399237

TM4SF5 accelerates G1/S phase progression via cytosolic p27Kip1 expression and RhoA activity.

Hyeonjung Kim1, Minkyung Kang, Sin-Ae Lee, Tae Kyoung Kwak, Oisun Jung, Hyo Jeong Lee, Sung-Hoon Kim, Jung Weon Lee.   

Abstract

Transmembrane 4 L six family member 5 (TM4SF5) causes epithelial-mesenchymal transition (EMT) for aberrant cell proliferation. However, the effects of TM4SF5 expression on cell cycle are unknown so far. In this study, using hepatocytes that either ectopically or endogenously express TM4SF5 and human hepatocarcinoma tissues, the role of TM4SF5 in G1/S phase progression was examined. We found that TM4SF5 expression accelerated G1/S phase progression with facilitated cyclin D1 and E expression and Rb phosphorylation. Furthermore, TM4SF5 enhanced trafficking of CDK4 and cyclin D1 into the nucleus and induced complex formation between them. However, TM4SF5-facilitated G1/S phase progression was blocked by silencing of p27Kip1 using siRNA or by infection of active RhoA. Pharmacological inhibition of ROCK accelerated the G1/S phase progression of control TM4SF5-unexpressing cells. Altogether, these observations suggest that TM4SF5 accelerates G1/S phase progression with facilitated CDK4/cyclin D1 entry into the nucleus, which might be supported by TM4SF5-mediated actin reorganization through cytosolic p27Kip1 expression and Rho GTPase activity. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20399237     DOI: 10.1016/j.bbamcr.2010.04.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Clinicopathological significance of TM4SF5 expression in human hepatocellular carcinoma tissues.

Authors:  Baojin Xu; Wu Lv; Xiaoyan Li; Lina Zhang; Jie Lin
Journal:  Oncol Lett       Date:  2019-04-03       Impact factor: 2.967

2.  Cross talk between the TM4SF5/focal adhesion kinase and the interleukin-6/STAT3 pathways promotes immune escape of human liver cancer cells.

Authors:  Jihye Ryu; Minkyung Kang; Mi-Sook Lee; Hye-Jin Kim; Seo Hee Nam; Haeng Eun Song; Doohyung Lee; Jung Weon Lee
Journal:  Mol Cell Biol       Date:  2014-06-09       Impact factor: 4.272

3.  A new tumour suppression mechanism by p27Kip1: EGFR down-regulation mediated by JNK/c-Jun pathway inhibition.

Authors:  Yong Fang; Yihong Wang; Yulei Wang; Yan Meng; Junlan Zhu; Honglei Jin; Jingxia Li; Dongyun Zhang; Yonghui Yu; Xue-Ru Wu; Chuanshu Huang
Journal:  Biochem J       Date:  2014-11-01       Impact factor: 3.857

4.  Insulin Promotes the Proliferation of Human Umbilical Cord Matrix-Derived Mesenchymal Stem Cells by Activating the Akt-Cyclin D1 Axis.

Authors:  Peng Li; Jinsong Wei; Xiang Gao; Bo Wei; Hao Lin; Rui Huang; Yanru Niu; Kyu Lim; Kaipeng Jing; Jiaqi Chu
Journal:  Stem Cells Int       Date:  2017-04-18       Impact factor: 5.443

5.  A peptide-CpG-DNA-liposome complex vaccine targeting TM4SF5 suppresses growth of pancreatic cancer in a mouse allograft model.

Authors:  Sangkyu Park; Dongbum Kim; Guang Wu; Harry Jung; Jeong-A Park; Hyung-Joo Kwon; Younghee Lee
Journal:  Onco Targets Ther       Date:  2018-12-03       Impact factor: 4.147

6.  TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo.

Authors:  Jia Cao; Jiachun Yang; Vijaya Ramachandran; Thiruvengadam Arumugam; Defeng Deng; Zhaoshen Li; Leiming Xu; Craig D Logsdon
Journal:  PLoS One       Date:  2015-12-28       Impact factor: 3.240

Review 7.  Membrane Proteins Involved in Epithelial-Mesenchymal Transition and Tumor Invasion: Studies on TMPRSS4 and TM4SF5.

Authors:  Semi Kim; Jung Weon Lee
Journal:  Genomics Inform       Date:  2014-03-31

8.  Targeting TM4SF5 with anti-TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cells.

Authors:  Sangkyu Park; Dongbum Kim; Jeong-A Park; Hyung-Joo Kwon; Younghee Lee
Journal:  Oncol Lett       Date:  2019-11-21       Impact factor: 2.967

9.  Circular RNA circCSPP1 promotes the occurrence and development of colon cancer by sponging miR-431 and regulating ROCK1 and ZEB1.

Authors:  Jin Wang; Lei Zhou; Bingxin Chen; Zhuwen Yu; Jianglei Zhang; Zhe Zhang; Chenrui Hu; Yanjin Bai; Xiaokang Ruan; Shengjia Wang; Jun Ouyang; Airong Wu; Xin Zhao
Journal:  J Transl Med       Date:  2022-01-31       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.